US 7,517,952 B1
Compositions and methods for the therapy and diagnosis of prostate cancer
Jiangchun Xu, Bellevue, Wash. (US); Davin C. Dillon, Issaquah, Wash. (US); Jennifer L. Mitcham, Redmond, Wash. (US); Susan L. Harlocker, Seattle, Wash. (US); Yuqiu Jiang, Kent, Wash. (US); Michael D. Kalos, Seattle, Wash. (US); Gary R. Fanger, Mill Creek, Wash. (US); Marc W. Retter, Carnation, Wash. (US); John A. Stolk, Bothell, Wash. (US); Craig H. Day, Seattle, Wash. (US); Thomas S. Vedvick, Federal Way, Wash. (US); Darrick Carter, Seattle, Wash. (US); Samuel X. Li, Redmond, Wash. (US); Aijun Wang, Issaquah, Wash. (US); Yasir A. W. Skeiky, Bellevue, Wash. (US); William T. Hepler, Seattle, Wash. (US); and Robert A. Henderson, Edmonds, Wash. (US)
Assigned to Corixa Corporation, Wilmington, Del. (US)
Filed on Jun. 13, 2000, as Appl. No. 9/593,793.
Application 09/593793 is a continuation in part of application No. 09/570737, filed on May 12, 2000, granted, now 7,202,342.
Application 09/570737 is a continuation in part of application No. 09/568100, filed on May 09, 2000, abandoned.
Application 09/568100 is a continuation in part of application No. 09/536857, filed on Mar. 27, 2000, abandoned.
Application 09/536857 is a continuation in part of application No. 09/483672, filed on Jan. 14, 2000, abandoned.
Application 09/483672 is a continuation in part of application No. 09/439313, filed on Nov. 12, 1999, granted, now 6,329,505.
Application 09/439313 is a continuation in part of application No. 09/352616, filed on Jul. 13, 1999, granted, now 6,395,278.
Application 09/352616 is a continuation in part of application No. 09/288946, filed on Apr. 09, 1999, abandoned.
Application 09/288946 is a continuation in part of application No. 09/232149, filed on Jan. 15, 1999, granted, now 6,465,611.
Application 09/232149 is a continuation of application No. 09/159812, filed on Sep. 23, 1998, granted, now 6,613,872.
Application 09/159812 is a continuation in part of application No. 09/115453, filed on Jul. 14, 1998, granted, now 6,657,056.
Application 09/115453 is a continuation in part of application No. 09/030607, filed on Feb. 25, 1998, granted, now 6,262,245.
Application 09/030607 is a continuation in part of application No. 09/020956, filed on Feb. 09, 1998, granted, now 6,261,562.
Application 09/020956 is a continuation in part of application No. 08/904804, filed on Aug. 01, 1997, abandoned.
Application 08/904804 is a continuation in part of application No. 08/806099, filed on Feb. 25, 1997, abandoned.
This patent is subject to a terminal disclaimer.
Int. Cl. C07K 14/00 (2006.01); A61K 39/00 (2006.01); C12Q 1/68 (2006.01); C07H 21/02 (2006.01)
U.S. Cl. 530—350  [424/184.1; 424/185.1; 435/6; 536/23.1] 3 Claims
 
1. An immunogenic composition comprising an immunostimulant which induces a predominantly Th1-type immune response and a polypeptide, wherein the polypeptide comprises SEQ ID NO: 113, and wherein the polypeptide stimulates a human cytotoxic T lymphocyte response specific for SEQ ID NO: 113.